Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.290
0.00 (0.00%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $165.4 million as of June 5, 2026. Its market cap has increased by 157.60% in one year.
Market Cap
165.40M
Enterprise Value
68.05M
1-Year Change
157.60%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $165.40M, a decrease of -73.25%. That is a compound annual growth rate of -23.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 165.40M | 29.41% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 173.70M |
| Spero Therapeutics | 172.55M |
| Turn Therapeutics | 171.13M |
| Innate Pharma | 169.51M |
| ADC Therapeutics | 167.89M |
| Tenaya Therapeutics | 167.54M |
| Precision BioSciences | 165.39M |
| Tiziana Life Sciences | 164.22M |